Reduced Frequency of Regulatory T Cells in Peripheral Blood Stem Cell Compared to Bone Marrow Transplantations

被引:21
作者
Blache, Celine [1 ,2 ,3 ]
Chauvin, Joe-Marc [1 ,2 ,3 ]
Marie-Cardine, Aude [4 ]
Contentin, Nathalie [5 ]
Pommier, Pascal [6 ]
Dedreux, Ingrid [1 ,2 ,3 ]
Francois, Stephanie [1 ,2 ,3 ]
Jacquot, Serge [1 ,2 ,3 ]
Bastit, Dominique [6 ]
Boyer, Olivier [1 ,2 ,3 ]
机构
[1] Fac Med, INSERM, U905, F-76000 Rouen, France
[2] Univ Rouen, IFRMP, Inst Biomed Res, Rouen, France
[3] Rouen Univ Hosp, Dept Immunol, Rouen, France
[4] Rouen Univ Hosp, Pediat Immunohematooncol Unit, Rouen, France
[5] Ctr Henri Becquerel, Dept Hematol, F-76038 Rouen, France
[6] Etab Francais Sang Normandie, Cell Therapy Unit, Rouen, France
关键词
Regulatory T cells; Hematopoietic stem cell transplant; Human; VERSUS-HOST-DISEASE; COLONY-STIMULATING FACTOR; G-CSF; GRAFT; MOBILIZATION; RISK; GVHD; LYMPHOCYTES; EXPRESSION;
D O I
10.1016/j.bbmt.2009.10.027
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Peripheral blood stem cell transplantation (PBSCT) is an alternative to bone marrow transplantation (BMT). Although CD4(+)CD25(+)CD127(lo) regulatory T cells (Tregs) have been shown to play important roles in the control of T cell reactivity, the Treg contents of both graft types have not been analyzed comparatively to date. We report herein that Treg frequencies are significantly reduced in PBSC compared to BM transplants. Furthermore, most Tregs from PBSC transplants are CD62L(lo), a phenotype reported to have poor suppressor activity. Both granulocyte-colony stimulating factor (G-CSF) administration and leukapheresis were found to contribute to the loss of CD62L(+) Tregs. Although higher T cell numbers are infused in PBSCT than in BMT, it is possible that the reduced Treg content of PBSC transplants may represent I factor contributing to the higher risk of GVHD reported after PBSCT. Biol Blood Marrow Transplant 16: 430-434 (2010) (C) 2010 American Society for Blood and Marrow Transplantation
引用
收藏
页码:430 / 434
页数:5
相关论文
共 30 条
[1]
Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: An individual patient data meta-analysis of nine randomized trials [J].
al-Jurf, M ;
Aranha, F ;
Annassetti, C ;
Apperley, JF ;
Baynes, R ;
Bensinger, WI ;
Blaise, D ;
Chaudhary, MA ;
Clarke, M ;
Cornelissen, JJ ;
Couban, S ;
Cutler, C ;
Djulbegovic, B ;
Gyger, M ;
Gratwohl, A ;
Heldal, D ;
Van der Holt, B ;
Hozo, I ;
Kuentz, M ;
Kumar, A ;
Lipton, J ;
Matchamm, J ;
Mohty, M ;
Morton, J ;
Panzarella, T ;
Powles, R ;
Richards, SM ;
Sahovic, E ;
Schmitz, N ;
Simpson, DR ;
Sirohi, B ;
Soares, HP ;
de Souza, CA ;
Vigorito, AC ;
Wheatley, K .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5074-5087
[2]
High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP:: A role for P2X7 receptors [J].
Aswad, F ;
Kawamura, H ;
Dennert, G .
JOURNAL OF IMMUNOLOGY, 2005, 175 (05) :3075-3083
[3]
CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis [J].
Boyer, O ;
Saadoun, D ;
Abriol, J ;
Dodille, M ;
Piette, JC ;
Cacoub, P ;
Klatzmann, D .
BLOOD, 2004, 103 (09) :3428-3430
[4]
CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease [J].
Cohen, JL ;
Trenado, A ;
Vasey, D ;
Klatzmann, D ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :401-406
[5]
The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graft-versus-host disease [J].
Cohen, Jose L. ;
Boyer, Olivier .
CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (05) :580-585
[6]
Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: A meta-analysis [J].
Cutler, C ;
Giri, S ;
Jeyapalan, S ;
Paniagua, D ;
Viswanathan, A ;
Antin, JH .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3685-3691
[7]
Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD [J].
Ermann, J ;
Hoffmann, P ;
Edinger, M ;
Dutt, S ;
Blankenberg, FG ;
Higgins, JP ;
Negrin, RS ;
Fathman, CG ;
Strober, S .
BLOOD, 2005, 105 (05) :2220-2226
[8]
CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential [J].
Fu, S ;
Yopp, AC ;
Mao, X ;
Chen, DM ;
Zhang, N ;
Chen, D ;
Mao, MW ;
Ding, YZ ;
Bromberg, JS .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (01) :65-78
[9]
Gu B, 1998, BLOOD, V92, P946
[10]
Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation [J].
Hoffmann, P ;
Ermann, J ;
Edinger, M ;
Fathman, CG ;
Strober, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :389-399